Cyberonics to Present at UBS Global Life Sciences Conference
10 September 2009 - 11:00PM
PR Newswire (US)
HOUSTON, Sept. 10 /PRNewswire-FirstCall/ -- Cyberonics, Inc.
(NASDAQ: CYBX) today announced that Dan Moore, President and Chief
Executive Officer, and Greg Browne, Chief Financial Officer, will
present at the UBS Global Life Sciences Conference in New York on
Tuesday, September 22, 2009 at 4:00 PM EDT. UBS will host a webcast
of the presentation live and by replay at
http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=82_IT8KY1C. The
replay will be available for 90 days following the conference.
Presentation slides will be available on-line at
http://www.cyberonics.com/ by 8:00 AM EDT on Tuesday, September 22,
2009. The presentation can also be accessed at
http://www.cyberonics.com/ by clicking on the link for this
webcast. Access to the webcast is not password protected. About
Cyberonics, Inc. and VNS Therapy(TM) Cyberonics, Inc. (NASDAQ:CYBX)
is a medical technology company with core expertise in
neuromodulation. The company developed and markets the Vagus Nerve
Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the
treatments of refractory epilepsy and treatment-resistant
depression. The VNS Therapy System uses a surgically implanted
medical device that delivers pulsed electrical signals to the vagus
nerve. Cyberonics markets the VNS Therapy System in selected
markets worldwide. Additional information on Cyberonics, Inc. and
VNS Therapy(TM) is available at http://www.cyberonics.com/ and
http://www.vnstherapy.com/. CONTACT INFORMATION: Greg Browne, CFO
Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281)
228-7262 Fax: (281) 218-9332 DATASOURCE: Cyberonics, Inc. CONTACT:
Greg Browne, CFO of Cyberonics, Inc., +1-281-228-7262, fax,
+1-281-218-9332, Web Site: http://www.cyberonics.com/
http://www.vnstherapy.com/
Copyright